Venglustat in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3 With Venglustat Monotherapy Extension
Clinical trial NCT02843035 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02843035
- Sponsor
- Genzyme, a Sanofi Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-04
- Primary completion
- 2026-10-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.